Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway

This publication has 69 references indexed in Scilit:

• The ErbB receptors and their role in cancer progression
  Experimental Cell Research, 2003
• Regulation of Estrogen Receptor Nuclear Export by Ligand-Induced and p38-Mediated Receptor Phosphorylation
  Molecular and Cellular Biology, 2002
• Estrogen receptor beta in breast cancer.
  Endocrine-Related Cancer, 2002
• Endocrine-responsive breast cancer and strategies for combating resistance
  Nature Reviews Cancer, 2002
• Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
  Cell, 2000
• NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells
  Oncogene, 2000
• Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer
  Oncogene, 2000
• Signaling by Tyrosine Kinases Negatively Regulates the Interaction between Transcription Factors and SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) Corepressor
  Molecular Endocrinology, 1998
• The significance ofheregulin in breast cancer tumor progression and drug resistance
  Breast Cancer Research and Treatment, 1996